Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication

OBJECTIVE: A prior longitudinal study demonstrates that free-water diffusion magnetic resonance imaging (dMRI) tracks progression in the substantia nigra (Ofori et al., 2015b). Here, we test the acute effects of antiparkinsonian medication on this established imaging progression marker for the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jae Woo, Burciu, Roxana G., Ofori, Edward, Shukla, Priyank, Okun, Michael S., Hess, Christopher W., Vaillancourt, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328740/
https://www.ncbi.nlm.nih.gov/pubmed/28275542
http://dx.doi.org/10.1016/j.nicl.2017.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328740/
https://www.ncbi.nlm.nih.gov/pubmed/28275542
http://dx.doi.org/10.1016/j.nicl.2017.02.012

Ejemplares similares